Hyperkalaemia Prevalence, Recurrence and Treatment in Haemodialysis
NCT04799067 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2023-07-06
Summary
The objective of this study is to evaluate the prevalence and recurrence of Hyperkalaemia (HK) in Chinese HD patients and to understand the treatment pattern of HK in China.
Conditions
- Hyperkalemia
- Hemodialysis
- Water-Electrolyte Imbalance
Interventions
- OTHER
-
observational study
no study drug involved, observational study.
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-17
- Primary Completion
- 2022-07-18
- Completion
- 2022-07-18
Countries
- China
Study Locations
More Related Trials
-
IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors
NCT04510792 ·Status: WITHDRAWN
-
The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients
NCT01455974 ·Status: COMPLETED ·Phase: NA
-
Double Blind Crossover Comparison of Diuretics in the Young
NCT00429897 ·Status: UNKNOWN ·Phase: NA
-
The Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients
NCT06736184 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Role of Isolated Nocturnal Hypertension Pattern in Nondialysis CKD
NCT03604003 ·Status: UNKNOWN ·Phase: NA
-
A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)
NCT03283267 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
NCT05056727 ·Status: TERMINATED ·Phase: PHASE3
-
Effects of Aliskiren in Elderly Hypertensive Chronic Kidney Disease (CKD) Patients
NCT01284114 ·Status: COMPLETED ·Phase: PHASE4
-
Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia
NCT03172702 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Low Versus Standard Dialysate Sodium on 48h Ambulatory BP in Patients With Intradialytic Hypertension
NCT05430438 ·Status: COMPLETED ·Phase: NA
-
Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study
NCT05347693 ·Status: COMPLETED ·Phase: PHASE4
-
Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency
NCT01172431 ·Status: COMPLETED ·Phase: PHASE4
-
Tissue K+ in Primary Hyperaldosteronism
NCT04251780 ·Status: COMPLETED
-
Comparison of Single and Combination Diuretics in Low-Renin Hypertension
NCT02351973 ·Status: UNKNOWN ·Phase: PHASE4
-
Haemodialysis Salt Reduction Study
NCT00141609 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.
NCT03528681 ·Status: COMPLETED ·Phase: PHASE3
-
Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.
NCT05173584 ·Status: UNKNOWN ·Phase: PHASE4
-
Protecting Renal Function in Chronic Kidney Disease Patients with Isolated Nighttime Hypertension
NCT06780865 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Examination of Potassium Levels in Saliva in ESRD Patients
NCT02596386 ·Status: UNKNOWN
-
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
NCT02040441 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Role of Skin Sodium Accumulation in Chronic Kidney Disease
NCT07020104 ·Status: RECRUITING ·Phase: NA
-
Effect of Hypertonic Sodium Chloride on Urinary Biomarkers in Healthy Subjects and Patients With Chronic Kidney Disease
NCT01623661 ·Status: COMPLETED ·Phase: NA
-
The Effects of Isotonic and Hypertonic Saline Infusion on Renal Biomarkers in Healthy Young Subjects
NCT01414088 ·Status: COMPLETED ·Phase: NA
-
Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
NCT06203236 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Potassium Canrenoate in Brain-dead Organ Donors: Randomized Controlled Clinical Trial
NCT04714710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2